Dr. Anand Prasad, MD

Dr. Prasad practices at University Hospital (San Antonio) in San Antonio, Texas.

Dr. Prasad's NPI, 1255538682, was assigned on June 29, 2007. Dr. Prasad graduated from LSU Health Sciences Center New Orleans - School of Medicine in 2000. Dr. Prasad holds Texas license L7116.

Dr. Prasad's primary practice is University Hospital (San Antonio), at 4502 Medical Dr, San Antonio, TX 78229 in Bexar County. The practice phone is (210) 358-4000.

Dr. Prasad's primary practice is University Hospital (San Antonio) in San Antonio, Texas. Dr. Prasad is also affiliated with University Hospital. The medical group on file is University Medicine Associates. Dmand AI also links Dr. Prasad to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Prasad practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Prasad's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Prasad is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Prasad's licenses on file in 2 states: Texas and California.

Dmand AI lists angioplasty, cardiac catheterization, circulation problems and pacemaker or defibrillator implantation among the conditions Dr. Prasad treats.

CMS data shows 607 Medicare services from Dr. Prasad across 14 procedure codes in 2024, for 232 Medicare patients. Medicare paid $44,652 for them.

CMS counts 232 Medicare patients who saw Dr. Prasad in 2024. The largest group is 65 to 74, with 104 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Prasad's median patient age at 73, with 42% women.

In 2024, Dr. Prasad wrote 1,617 Medicare Part D claims for 259 patients. 81% of them were for generic drugs. CMS names the drug for 1,407 of them, across 27 drugs with 11 or more claims each, at $265,689 in total drug cost. In 2023, CMS named 1,283 claims across 27 drugs.

Dr. Prasad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 171 papers to Dr. Prasad, published from 2007 to 2025. 2017 was the busiest year, with 13. The most frequent topics are Peripheral Arterial Disease, Endovascular Procedures and Acute Kidney Injury. Dr. Prasad has published most often in Catheter Cardiovasc Interv. Dr. Prasad's most frequent co-authors are Subhash Banerjee, MD, Shweta Bansal, MD and Ehrin J. Armstrong, MD.

Dmand AI links Dr. Prasad to 5 clinical trials. 2 are still active or recruiting. Conditions studied include Peripheral Arterial Disease, Peripheral Vascular Diseases and Acute Kidney Injury.

CMS Open Payments shows 765 general payments to Dr. Prasad from 49 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 41% of the total. AstraZeneca Pharmaceuticals LP paid the most, $95,323. It also lists 1 research payment totaling $1,500 in 2020.

Dmand AI lists 2 awards for Dr. Prasad, most recently CMS Stage 1 EHR in 2013.

Dr. Prasad graduated from LSU Health Sciences Center New Orleans - School of Medicine in 2000. Dr. Prasad is a member of ACC.

Dr. Prasad is in network with 22 carriers, including Elevance, Aetna and United Healthcare. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.